Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Entrada Therapeutics (TRDA) Return on Assets (2022 - 2025)

Entrada Therapeutics (TRDA) has 4 years of Return on Assets data on record, last reported at 0.36% in Q4 2025.

  • For Q4 2025, Return on Assets fell 49.0% year-over-year to 0.36%; the TTM value through Dec 2025 reached 0.36%, down 49.0%, while the annual FY2025 figure was 0.32%, 45.0% down from the prior year.
  • Return on Assets reached 0.36% in Q4 2025 per TRDA's latest filing, down from 0.24% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.19% in Q2 2024 and bottomed at 0.36% in Q4 2025.
  • Average Return on Assets over 4 years is 0.08%, with a median of 0.04% recorded in 2023.
  • Peak YoY movement for Return on Assets: skyrocketed 36bps in 2024, then tumbled -49bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 0.36% in 2022, then skyrocketed by 96bps to 0.01% in 2023, then surged by 966bps to 0.12% in 2024, then crashed by -400bps to 0.36% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.36% in Q4 2025, 0.24% in Q3 2025, and 0.16% in Q2 2025.